The Biotech Growth Trust PLC
BIOG.L · LSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | £238 | £349 | £315 | £372 |
| - Cash | £8 | £2 | £3 | £0 |
| + Debt | £0 | £47 | £20 | £32 |
| Enterprise Value | £229 | £394 | £333 | £404 |
| Revenue | -£77 | £80 | -£38 | -£210 |
| % Growth | -196.4% | 313.4% | 82% | – |
| Gross Profit | -£79 | £78 | -£43 | -£215 |
| % Margin | 101.7% | 97.1% | 114.1% | 102.3% |
| EBITDA | -£83 | £0 | £0 | -£11 |
| % Margin | 106.5% | 0% | -0% | 5.1% |
| Net Income | -£83 | £75 | -£41 | -£202 |
| % Margin | 106.7% | 92.8% | 109.7% | 96.5% |
| EPS Diluted | -2.62 | 2.07 | -1.03 | -4.88 |
| % Growth | -226.6% | 301% | 78.9% | – |
| Operating Cash Flow | -£5 | -£4 | -£6 | -£12 |
| Capital Expenditures | £0 | £0 | £0 | -£1 |
| Free Cash Flow | -£5 | -£4 | -£6 | -£13 |